Viewing Study NCT05267535


Ignite Creation Date: 2025-12-24 @ 10:19 PM
Ignite Modification Date: 2025-12-25 @ 7:52 PM
Study NCT ID: NCT05267535
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-06-21
First Post: 2022-02-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Piromelatine 20 mg in Participants With Mild Dementia Due to Alzheimer's Disease
Sponsor: Neurim Pharmaceuticals Ltd.
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2022-05-12
Start Date Type: ACTUAL
Primary Completion Date: 2025-06
Primary Completion Date Type: ESTIMATED
Completion Date: 2025-06
Completion Date Type: ESTIMATED
First Submit Date: 2022-02-22
First Submit QC Date: None
Study First Post Date: 2022-03-04
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2024-06-19
Last Update Post Date: 2024-06-21
Last Update Post Date Type: ACTUAL